Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PKCβ inhibitor is an inhibitor of PKCβ1 and PKCβ2 (IC50s = 21 and 5 nM, respectively).1 It is selective for PKCβ1 and PKCβ2 over PKCα, PKCε, and PKCγ (IC50s = 331, 2,807, and >1,000 nM, respectively), as well as JAK1, JAK2, and tyrosine kinase 2 (TYK2; IC50s = 770, 3,850, and 2,310 nM, respectively), but also inhibits JAK3 (IC50 = 17 nM).1,2 PKCβ inhibitor (14 µM) induces apoptosis and inhibits cell cycle progression in 2F7 AIDS-related Burkitt’s lymphoma cells.3
WARNING This product is not for human or veterinary use.
1. Synthesis of anilino-
2. Anilino-
3. Protein kinase C-